The NASH-TAG Conference unites leaders in clinical, academic, and pharmaceutical fields to improve outcomes for patients with NASH. IMA Clinical Research is a recognized leader in NASH studies, building a large patient database through community partnerships. With advanced imaging capabilities and high enrollment rates, especially in diverse communities, we are at the forefront of NASH research. Connect with our team—Kevin Short and Dr. Yu-Mei Liu—to discuss how our site network can bring new NASH treatments to patients.

Join IMA Clinical Research at Booth 1030 during SCOPE Summit 2025 to connect with our team and learn how our nationwide site network delivers diverse patient access, experienced PIs, and efficient study start-up. Key members of our business development, operations, and executive teams will be available to discuss partnership opportunities. Set up a meeting today!

Our Manhattan site has moved to a larger space on the 3rd floor of their previous location. Join us at our new location and tour our space, meet the staff, and learn about our current research studies. Refreshments provided.

The SCRS IncluDE Site Solutions Summit™ brings clinical research industry leaders together to enable collaboration, developing intentional solutions for ensuring access to clinical trials. This year, Mireya Medina, Site Director, and Olivia Bochel, Associate Director of Business Development, will represent our team.  Contact us to schedule a time to connect!

Join IMA Clinical Research at Booth 561 during World Vaccine Congress 2025 to connect with our team and learn how our nationwide site network delivers diverse patient access, experienced PIs, and efficient study start-up.

Representing our team will be Jalene Barnhart, Senior Director of Business Development; Kevin Short, Director of Business Development; Priya Selvarajah, Regional Site Director and Samar Hameed, MD, Principal Investigator. Set up a meeting today!

Attending on behalf of IMA Clinical Research, Alyssa Bochen, PA-C, MMS, CPI, Regional Site Director, and Angel Goewey, MBA, CCRC, Site Director, will join academic investigators, industry scientists, U.S. and international regulators from FDA and EMA, National Institutes of Health components including NIMH, NIDA, NIAAA and many other professionals working in drug development and clinical trials who will all come together to foster improvement in the quality of psychopharmacology practice.

The intersection of technology and best practice leads to breakthroughs within the clinical research enterprise. SCRS West: Clinical Tech & Innovation Summit focuses on new thinking and collaborative problem-solving to power the partnerships research needs in 2025 and beyond. This year, Alyssa Boschen, PA-C, MMS, CPI, Regional Site Director, and Angel Goewey, MBA, CCRC, Site Director, will represent our team. We are excited to announce that Alyssa Boschen will join the panel for 'Assessing Tech Readiness: Site Implementation Checklist'. You won't want to miss this important session!